FDA Inspection
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA Inspection, Sep 5, 2025
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on September 5, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bad39678-8eb7-42c7-b820-7b3bab50ca4f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1286862
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Aurobindo Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| June 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurobindo Pharma Limited
- FDA Inspection 1241780 - 2023-03-09
- FDA Inspection 1118385 - 2020-02-21
- FDA Inspection 1046218 - 2018-03-16
- FDA Inspection 847151 - 2013-08-16
- FDA Inspection 793023 - 2012-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.